These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 16431393

  • 1. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions.
    Nisar-ur-Rahman, K H Y, Jia Woei W, Khan NA.
    Pak J Pharm Sci; 2005 Apr; 18(2):19-23. PubMed ID: 16431393
    [Abstract] [Full Text] [Related]

  • 2. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 3. Sustained-release of buspirone HCl by co spray-drying with aqueous polymeric dispersions.
    Al-Zoubi N, Alkhatib HS, Bustanji Y, Aiedeh K, Malamataris S.
    Eur J Pharm Biopharm; 2008 Jun; 69(2):735-42. PubMed ID: 18291632
    [Abstract] [Full Text] [Related]

  • 4. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
    Terebesi I, Bodmeier R.
    Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
    [Abstract] [Full Text] [Related]

  • 5. pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP.
    Dashevsky A, Kolter K, Bodmeier R.
    Eur J Pharm Biopharm; 2004 Jul; 58(1):45-9. PubMed ID: 15207536
    [Abstract] [Full Text] [Related]

  • 6. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H, McGinity JW.
    Int J Pharm; 2006 Oct 12; 323(1-2):11-7. PubMed ID: 16815652
    [Abstract] [Full Text] [Related]

  • 7. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A, Afrasiabi Garekani H, Sadeghi F, Azimaie M.
    Int J Pharm; 2005 Nov 23; 305(1-2):22-30. PubMed ID: 16236475
    [Abstract] [Full Text] [Related]

  • 8. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D, Zheng W, Coots LB, McGinity JW.
    Eur J Pharm Biopharm; 2007 Sep 23; 67(2):464-75. PubMed ID: 17451929
    [Abstract] [Full Text] [Related]

  • 9. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F, Moreno P, Basit AW.
    Eur J Pharm Biopharm; 2010 Feb 23; 74(2):311-5. PubMed ID: 19932177
    [Abstract] [Full Text] [Related]

  • 10. Crystal growth formation in melt extrudates.
    Bruce C, Fegely KA, Rajabi-Siahboomi AR, McGinity JW.
    Int J Pharm; 2007 Aug 16; 341(1-2):162-72. PubMed ID: 17524578
    [Abstract] [Full Text] [Related]

  • 11. Properties of melt extruded enteric matrix pellets.
    Schilling SU, Shah NH, Waseem Malick A, McGinity JW.
    Eur J Pharm Biopharm; 2010 Feb 16; 74(2):352-61. PubMed ID: 19782133
    [Abstract] [Full Text] [Related]

  • 12. Effects of film coating thickness and drug layer uniformity on in vitro drug release from sustained-release coated pellets: a case study using terahertz pulsed imaging.
    Ho L, Cuppok Y, Muschert S, Gordon KC, Pepper M, Shen Y, Siepmann F, Siepmann J, Taday PF, Rades T.
    Int J Pharm; 2009 Dec 01; 382(1-2):151-9. PubMed ID: 19716407
    [Abstract] [Full Text] [Related]

  • 13. Compression of pellets coated with various aqueous polymer dispersions.
    Dashevsky A, Kolter K, Bodmeier R.
    Int J Pharm; 2004 Jul 26; 279(1-2):19-26. PubMed ID: 15234790
    [Abstract] [Full Text] [Related]

  • 14. Preparation and characterization of ibuprofen pellets based on Eudragit RS PO and RL PO or their combination.
    Abbaspour MR, Sadeghi F, Garekani HA.
    Int J Pharm; 2005 Oct 13; 303(1-2):88-94. PubMed ID: 16153792
    [Abstract] [Full Text] [Related]

  • 15. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD, Liu Y, Tang X, Zhang Q.
    Eur J Pharm Biopharm; 2006 Oct 13; 64(2):185-92. PubMed ID: 16797948
    [Abstract] [Full Text] [Related]

  • 16. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU, Bruce CD, Shah NH, Malick AW, McGinity JW.
    Int J Pharm; 2008 Sep 01; 361(1-2):158-68. PubMed ID: 18582547
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.
    Guan T, Wang J, Li G, Tang X.
    Pharm Dev Technol; 2011 Jun 01; 16(3):269-77. PubMed ID: 20214529
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
    Zhu Y, Mehta KA, McGinity JW.
    Pharm Dev Technol; 2006 Jun 01; 11(3):285-94. PubMed ID: 16895839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.